Cambridge, Massachusetts-based Carmine Therapeutics inked a research collaboration deal with Japan’s Takeda Pharmaceutical to develop and commercialize non-viral gene therapies for two rare diseases.
https://www.pharmalive.com/wp-content/uploads/2020/06/Takeda-and-Carmine-Enter-900-Million-Non-Viral-Gene-Therapy-Collaboration-BioSpace-6-30-20.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2020-06-30 11:34:102020-07-07 18:23:53Takeda and Carmine Enter $900 Million Non-Viral Gene Therapy Collaboration